Prof Jonathon Edwards to be IiME Rituximab trial advisor

Esther12

Senior Member
Messages
13,774
Likes
28,362
Good news.

Hopefully he might be able to advance work on finding a way of identifying those patients most likely to benefit. Linking the rituximab CFS work to others working in a similar area but outside of CFS seems like a really positive move.
 

Gemini

Senior Member
Messages
1,175
Likes
2,589
Location
East Coast USA
Good news.

Hopefully he might be able to advance work on finding a way of identifying those patients most likely to benefit. Linking the rituximab CFS work to others working in a similar area but outside of CFS seems like a really positive move.
Esther,

You're absolutely right!

In RA they can identify non-responders to rituximab using an interferon [gene expression] signature:

"The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients, " Arthritis Res Ther, April 2012

http://www.ncbi.nlm.nih.gov/pubmed/22540992

Let's hope the Professor is familiar with this groundbreaking work in another disease & can apply it to ME/CFS.